Lazar Popovic, Head of Clinic for Medical Oncology at Oncology Institute of Vojvodina, shared a post on LinkedIn:
“Very happy and proud to share our newly published article in the most influential breast cancer journal “The Breast“.
This one of the largest (if not the largest) biomarker-included RWD cohort in Triple Negative Breast Cancer ever published: VANESSA study. VANESSA is non-interventional study, I had a privilege to lead, together with my colleague Dr Corrado D’Arrigo from Wales. Included 2700 patients from 19 countries on 4 continents. I would like to thank all the investigators, co-authors and especially João Mouta and whole Roche team for opportunity, help and huge support.”
Title: Treatment patterns and clinical outcomes according to PD-L1 status in >2000 patients with early-stage or metastatic triple-negative breast cancer treated in the real-world setting: VANESSA study results
Authors: Lazar Popovic, Romualdo Barroso-Sousa, Nagi S. El Saghir, Rebecca Dent, Sitki Tuzlali, Saad Akhtar, Elona Juozaityte, Janis Eglitis, Dinesh C. Doval, Carlos A. Castaneda, Alisan Zirtiloglu, Götz Hartleben, Regula Deurloo, Paula Toron, Iman Estaytieh, Enya Weber, João Mouta, Corrado D’Arrigo
Read The Full Article
More posts featuring Lazar Popovic on OncoDaily.
